Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe Record History page version was updated from v3.5.3 to v3.5.4, representing a new published revision.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Record History page now shows revision v3.5.3, replacing the previous v3.5.2. It reflects a small update to the page's revision history rather than changes to the study content.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the history section.SummaryDifference0.1%

- Check108 days agoChange DetectedRevision: v3.4.2 added; earlier notices about government funding status and the v3.4.1 revision were removed.SummaryDifference0.8%

Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.